Krystexxa
Active substance: pegloticase
INJECTION, SOLUTION · PEGLOTICASE 8 mg/mL
United StatesActive
Marketing holder: Horizon Therapeutics USA, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- PEGLOTICASE · 8 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3092-7be7-b03a-7f499b98acd9,01a12097-5aa9-79c6-83fe-cff174dfcaaa;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 75987-080
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 75987-080 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 75987-080 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 75987-080 · Verified 2026-10-09 · open in source